Catherine Stehman-Breen

Catherine Stehman-Breen

Directeur Technique/Scientifique/R&D chez DYNE THERAPEUTICS, INC.

Fortune : 2 M $ au 30/04/2024

61 ans
Health Technology
Consumer Services
Finance

Provenance du réseau au premier degré de Catherine Stehman-Breen

EntitéType d'entitéIndustrie
Public Company Pharmaceuticals: Major 286
The University of Chicago
169
College/University Other Consumer Services 169
130
College/University Other Consumer Services 130
79
Private Company Investment Managers 79
Colby College
44
College/University Other Consumer Services 44
Public Company Biotechnology 23
Public Company Pharmaceuticals: Major 21
Public Company Pharmaceuticals: Major 19
Public Company Pharmaceuticals: Major 17
11
Holding Company Pharmaceuticals: Major 11
11
Subsidiary Investment Managers 11
Public Company Pharmaceuticals: Major 8
3
Holding Company Biotechnology 3
2
Subsidiary Biotechnology 2
UW School of Public Health
1
College/University Other Consumer Services 1

Graphique Sociétés connectées au second degré

Relation dans plusieurs entreprises

Sociétés connectées à Catherine Stehman-Breen via son réseau personnel

SociétéSecteurPersonnes liéesPoste principal
Harvard Business School College/University

Kevin Sharer

Peter Barrett

Gustav Christensen

Robert Bradway

Marc M. P. de Garidel

Faraz Ali

Amy Burroughs

Corporate Officer/Principal

Corporate Officer/Principal

Masters Business Admin

Masters Business Admin

Masters Business Admin

Masters Business Admin

Masters Business Admin

College/University

N. Coles

Tyler Jacks

Jernej Godec

Jeenjoo Kang

Maya Bermingham

Maurizio Fazio

Graduate Degree

Undergraduate Degree

Doctorate Degree

Undergraduate Degree

Undergraduate Degree

Doctorate Degree

Medical Specialties

Edward Kaye

Dennis Fenton

Cameron McDonough

Carlo Incerti

Faraz Ali

Corporate Officer/Principal

Director/Board Member

Corporate Officer/Principal

Chief Tech/Sci/R&D Officer

Corporate Officer/Principal

Harvard Medical School College/University

Jeff Jonas

N. Coles

Dave Grayzel

Kevin Bitterman

Cameron McDonough

Doctorate Degree

Corporate Officer/Principal

Doctorate Degree

Doctorate Degree

Graduate Degree

BLUEBIRD BIO, INC. Biotechnology

John Maraganore

Jeffrey Walsh

Susanna High

Mark Angelino

Faraz Ali

Director/Board Member

Director of Finance/CFO

Chief Operating Officer

Corporate Officer/Principal

Corporate Officer/Principal

KALEIDO BIOSCIENCES, INC. Pharmaceuticals: Major

Anthony Quinn

Joshua Brumm

Amy Reilly

Bonnie Bassler

Rick Scalzo

Director/Board Member

Director of Finance/CFO

Investor Relations Contact

Director/Board Member

Comptroller/Controller/Auditor

Biotechnology

David Goeddel

David W. Beier

Ankit Mahadevia

June Lee

Amy Burroughs

Corporate Officer/Principal

General Counsel

Corporate Officer/Principal

Chief Tech/Sci/R&D Officer

Corporate Officer/Principal

BRISTOL-MYERS SQUIBB COMPANY Pharmaceuticals: Major

Robert Williams

N. Coles

Charles Rowland

Mark Angelino

Ronald Cooper

Director/Board Member

Corporate Officer/Principal

Director of Finance/CFO

Corporate Officer/Principal

Corporate Officer/Principal

KYMERA THERAPEUTICS, INC. Biotechnology

John Maraganore

Bruce Booth

Donald Nicholson

Nello Mainolfi

Steven Robinette

Director/Board Member

Founder

Director/Board Member

Founder

Private Equity Investor

University of California San Diego College/University

David Goeddel

Phillip Samayoa

Aimee Raleigh

Jennifer Drimmer

Undergraduate Degree

Doctorate Degree

Doctorate Degree

Undergraduate Degree

Biotechnology

Bruce Booth

Ankit Mahadevia

Thomas Hughes

Donald Nicholson

Founder

Corporate Officer/Principal

Consultant / Advisor

Chief Executive Officer

The Johns Hopkins University College/University

N. Coles

Ankit Mahadevia

Bonnie Bassler

June Lee

Director/Board Member

Corporate Officer/Principal

Doctorate Degree

Undergraduate Degree

College/University

Robert Williams

N. Coles

Romesh R. Subramanian

Aimee Raleigh

Corporate Officer/Principal

Doctorate Degree

Graduate Degree

Undergraduate Degree

Investment Managers

Jeffrey Walsh

Mark Angelino

Chelsea Johnson

Andrea DiMella

Private Equity Investor

Private Equity Investor

Private Equity Analyst

Private Equity Investor

Miscellaneous Commercial Services

David Goeddel

Huda Zoghbi

Deepak Srivastava

Bonnie Bassler

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Yale University College/University

Jason Rhodes

Jeffrey Walsh

Vic Myer

Antoinette Paone

Undergraduate Degree

Undergraduate Degree

Doctorate Degree

Graduate Degree

ALNYLAM PHARMACEUTICALS, INC. Pharmaceuticals: Major

John Maraganore

Peter Barrett

Jason Rhodes

Susanna High

Chief Executive Officer

Director/Board Member

Corporate Officer/Principal

Director/Board Member

DYAX CORP. Pharmaceuticals: Major

Dave Grayzel

Gustav Christensen

Jodie Morrison

John Najim

Corporate Officer/Principal

Chief Executive Officer

Chief Tech/Sci/R&D Officer

Corporate Officer/Principal

Massachusetts Institute of Technology College/University

Tyler Jacks

Mark Angelino

Phillip Samayoa

Dannielle Appelhans

Corporate Officer/Principal

Doctorate Degree

Undergraduate Degree

Graduate Degree

BIOGEN INC. Pharmaceuticals: Major

Michael Kelly

John Maraganore

Douglas Kerr

Andrea DiMella

Director of Finance/CFO

Corporate Officer/Principal

Director/Board Member

Private Equity Investor

Miscellaneous Commercial Services

Dennis Fenton

John Maraganore

N. Coles

Jean-Francois Formela

Director/Board Member

Director/Board Member

Director/Board Member

Director/Board Member

Miscellaneous Commercial Services

Kevin Bitterman

Ankit Mahadevia

Chelsea Johnson

Director/Board Member

Director/Board Member

Founder

Miscellaneous Commercial Services

Robert Alexander Ingram

Robert Bradway

David Reese

Founder

Director/Board Member

Director/Board Member

College/University

Edward Hurwitz

Ommer Chohan

Vic Myer

Undergraduate Degree

Masters Business Admin

Undergraduate Degree

Medical/Nursing Services

Jeffrey Walsh

Faraz Ali

Karah Parschauer

Director/Board Member

Director/Board Member

Director/Board Member

Miscellaneous Commercial Services

David Goeddel

Huda Zoghbi

Bonnie Bassler

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

The Trustees of Columbia University in The City of New York College/University

Jean-Francois Formela

Timothy Hoey

David Weinreich

Masters Business Admin

Doctorate Degree

Undergraduate Degree

College/University

Peter Barrett

David Lubner

Douglas Kerr

Doctorate Degree

Undergraduate Degree

Masters Business Admin

Biotechnology

Jean-Francois Formela

Ommer Chohan

Steven Robinette

Founder

Director/Board Member

Private Equity Investor

Bentley University College/University

David Lubner

John Najim

Antoinette Paone

Graduate Degree

Masters Business Admin

Masters Business Admin

Pharmaceuticals: Major

Jean-Francois Formela

Kevin Bitterman

Thomas Hughes

Director/Board Member

Director/Board Member

Chief Executive Officer

Investment Managers

David Goeddel

Huda Zoghbi

Jeenjoo Kang

Private Equity Investor

Private Equity Investor

Private Equity Analyst

SPERO THERAPEUTICS, INC. Biotechnology

Jean-Francois Formela

Ankit Mahadevia

Michael Gladstone

Director/Board Member

Founder

Chief Operating Officer

Miscellaneous Commercial Services

Kevin Sharer

Bruce Booth

Ankit Mahadevia

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Biotechnology

Jean-Francois Formela

Dave Grayzel

Ankit Mahadevia

Founder

Chief Executive Officer

Founder

TRANSLATE BIO, INC. Biotechnology

Jean-Francois Formela

Ankit Mahadevia

Romesh R. Subramanian

Founder

Director/Board Member

Founder

Pharmaceuticals: Major

John Maraganore

Susanna High

Mark Angelino

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

MOMENTA PHARMACEUTICALS, INC. Pharmaceuticals: Major

Peter Barrett

Jeffrey Hrkach

Mark Angelino

Chairman

Corporate Officer/Principal

Corporate Officer/Principal

SURFACE ONCOLOGY, INC. Biotechnology

Dave Grayzel

Cameron McDonough

Michael Gladstone

Chief Executive Officer

Director/Board Member

Chief Operating Officer

Biotechnology

Dave Grayzel

Jodie Morrison

Michael Gladstone

Founder

Chief Executive Officer

Founder

Investment Managers

Kevin Sharer

Dennis Fenton

David W. Beier

Chief Executive Officer

Chief Operating Officer

General Counsel

College/University

Kevin Sharer

Ronald Sugar

Robert Bradway

Director/Board Member

Director/Board Member

Director/Board Member

Pharmaceuticals: Major

Jean-Francois Formela

Dave Grayzel

Ankit Mahadevia

Director/Board Member

Chief Executive Officer

Founder

Statistiques

Internationale

Etats-Unis 50
Belgique 2

Sectorielle

Health Technology 27
Consumer Services 13
Commercial Services 8
Finance 5
Health Services 2

Opérationnelle

Director/Board Member 576
Corporate Officer/Principal 253
Independent Dir/Board Member 188
Chairman 151
Chief Executive Officer 97
-40% Offre à Durée Limitée : Nos abonnements vous guident vers les meilleurs investissements de demain.
PROFITEZ-EN MAINTENANT